|
|
|
Insider
Information: |
Waltermire Robert E. |
Relationship: |
|
City: |
West Conshohocken |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
6,536 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,341,514 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
6,536 |
|
|
Total
Value |
$1,341,514 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Madrigal Pharmaceuticals Inc |
MDGL |
|
2024-01-23 |
6,536 |
2023-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,419 |
6,536 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2024-01-16 |
4 |
D |
$243.92 |
$134,156 |
D/D |
(550) |
5,117 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-12-15 |
4 |
S |
$236.00 |
$477,000 |
D/D |
(2,000) |
5,667 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-12-15 |
4 |
OE |
$87.92 |
$175,840 |
D/D |
2,000 |
7,667 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-12-14 |
4 |
S |
$232.00 |
$465,000 |
D/D |
(2,000) |
5,667 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-12-14 |
4 |
OE |
$87.92 |
$175,840 |
D/D |
2,000 |
7,667 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-12-13 |
4 |
S |
$225.00 |
$563,500 |
D/D |
(2,500) |
5,667 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-12-13 |
4 |
OE |
$87.92 |
$219,800 |
D/D |
2,500 |
8,167 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-12-12 |
4 |
S |
$216.00 |
$283,200 |
D/D |
(1,300) |
5,667 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-12-12 |
4 |
OE |
$87.92 |
$114,296 |
D/D |
1,300 |
6,967 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-03-01 |
4 |
S |
$273.44 |
$1,372,081 |
D/D |
(5,000) |
5,667 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-03-01 |
4 |
OE |
$87.92 |
$439,600 |
D/D |
5,000 |
10,667 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-02-28 |
4 |
S |
$271.03 |
$1,360,357 |
D/D |
(5,000) |
5,667 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-02-28 |
4 |
OE |
$87.92 |
$439,600 |
D/D |
5,000 |
10,667 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Senior VP, Chief Pharma Dev. |
|
2023-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,667 |
5,667 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|